Jill Glesner1, Stephanie Filep1, Lisa D Vailes1, Sabina Wünschmann1, Martin D Chapman1, Giovanni Birrueta2, April Frazier2, Kyoung Yong Jeong3, Coby Schal4, Leonard Bacharier5, Avraham Beigelman5, Paula Busse6, Véronique Schulten2, Alessandro Sette7, Anna Pomés8. 1. Indoor Biotechnologies, Charlottesville, Va. 2. La Jolla Institute for Allergy & Immunology, La Jolla, Calif. 3. Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea. 4. Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, NC. 5. Department of Pediatrics, Washington University School of Medicine, St Louis, Mo. 6. Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY. 7. La Jolla Institute for Allergy & Immunology, La Jolla, Calif; Department of Medicine, University of California San Diego, La Jolla, Calif. 8. Indoor Biotechnologies, Charlottesville, Va. Electronic address: apomes@inbio.com.
Abstract
BACKGROUND: Cockroach allergens are an important cause of IgE-mediated sensitization in inner-city asthmatic patients. However, cockroach extracts used for diagnosis and immunotherapy are not standardized. OBJECTIVE: We sought to determine the allergen content of nonstandardized German cockroach extracts and the levels of sensitization to an expanded set of cockroach allergens as determinants of in vitro extract potency for IgE reactivity. METHODS: Twelve German cockroach extracts were compared for allergen content and potency of IgE reactivity. Bla g 1, Bla g 2, and Bla g 5 were measured by using immunoassays. IgE antibody levels to 8 purified recombinant allergens from groups 1, 2, 4, 5, 6, 7, 9, and 11 were measured by using ImmunoCAP. IgE antibody binding inhibition assays were performed to assess extract in vitro potencies (concentration inhibiting 30% of the total IgE antibody-binding inhibition) relative to an arbitrarily selected reference extract in 5 patients with cockroach allergy. RESULTS: Allergen levels were highly variable. Three new major allergens (groups 6, 9, and 11), were identified among highly cockroach-sensitized subjects (CAP class ≥ 3). Sensitization profiles were unique per subject without immunodominant allergens. The sum of IgE to 8 allergen components showed a good correlation with cockroach-specific IgE levels (r = 0.88, P < .001). In vitro potencies varied among different extracts per subject and among subjects for each extract. CONCLUSIONS: The in vitro potency of German cockroach extracts for IgE reactivity depends on allergen content and allergen-specific IgE titers of patients with cockroach allergy. These factors are relevant for selection of potent extracts to be used for immunotherapy and for the design and interpretation of data from immunotherapy trials.
BACKGROUND: Cockroach allergens are an important cause of IgE-mediated sensitization in inner-city asthmatic patients. However, cockroach extracts used for diagnosis and immunotherapy are not standardized. OBJECTIVE: We sought to determine the allergen content of nonstandardized German cockroach extracts and the levels of sensitization to an expanded set of cockroach allergens as determinants of in vitro extract potency for IgE reactivity. METHODS: Twelve German cockroach extracts were compared for allergen content and potency of IgE reactivity. Bla g 1, Bla g 2, and Bla g 5 were measured by using immunoassays. IgE antibody levels to 8 purified recombinant allergens from groups 1, 2, 4, 5, 6, 7, 9, and 11 were measured by using ImmunoCAP. IgE antibody binding inhibition assays were performed to assess extract in vitro potencies (concentration inhibiting 30% of the total IgE antibody-binding inhibition) relative to an arbitrarily selected reference extract in 5 patients with cockroach allergy. RESULTS: Allergen levels were highly variable. Three new major allergens (groups 6, 9, and 11), were identified among highly cockroach-sensitized subjects (CAP class ≥ 3). Sensitization profiles were unique per subject without immunodominant allergens. The sum of IgE to 8 allergen components showed a good correlation with cockroach-specific IgE levels (r = 0.88, P < .001). In vitro potencies varied among different extracts per subject and among subjects for each extract. CONCLUSIONS: The in vitro potency of German cockroach extracts for IgE reactivity depends on allergen content and allergen-specific IgE titers of patients with cockroach allergy. These factors are relevant for selection of potent extracts to be used for immunotherapy and for the design and interpretation of data from immunotherapy trials.
Authors: James Hindley; Sabina Wünschmann; Shama M Satinover; Judith A Woodfolk; Fook Tim Chew; Martin D Chapman; Anna Pomés Journal: J Allergy Clin Immunol Date: 2006-05-02 Impact factor: 10.793
Authors: Shama M Satinover; Amanda J Reefer; Anna Pomes; Martin D Chapman; Thomas A E Platts-Mills; Judith A Woodfolk Journal: J Allergy Clin Immunol Date: 2005-04 Impact factor: 10.793
Authors: Alla Gustchina; Mi Li; Sabina Wünschmann; Martin D Chapman; Anna Pomés; Alexander Wlodawer Journal: J Mol Biol Date: 2005-04-29 Impact factor: 5.469
Authors: Anna Pomés; Martin D Chapman; Lisa D Vailes; Tom L Blundell; Venugopal Dhanaraj Journal: Am J Respir Crit Care Med Date: 2002-02-01 Impact factor: 21.405
Authors: J E Slater; R James; J A Pongracic; A H Liu; S Sarpong; H A Sampson; S M Satinover; J A Woodfolk; H E Mitchell; P J Gergen; P A Eggleston Journal: Clin Exp Allergy Date: 2007-07 Impact factor: 5.018
Authors: Anna Pomés; Jill Glesner; Agustin Calatroni; Cindy M Visness; Robert A Wood; George T O'Connor; Meyer Kattan; Leonard B Bacharier; Lisa M Wheatley; James E Gern; William W Busse Journal: J Allergy Clin Immunol Date: 2019-06-13 Impact factor: 10.793
Authors: Véronique Schulten; April Frazier; Agustin Calatroni; Meyer Kattan; Leonard B Bacharier; George T O'Connor; Megan T Sandel; Robert A Wood; Lisa M Wheatley; Alkis Togias; Cynthia M Visness; Amy Dresen; James E Gern; Alessandro Sette Journal: Clin Exp Allergy Date: 2019-05-29 Impact factor: 5.018
Authors: Maksymilian Chruszcz; Fook Tim Chew; Karin Hoffmann-Sommergruber; Barry K Hurlburt; Geoffrey A Mueller; Anna Pomés; Juha Rouvinen; Mayte Villalba; Birgitta M Wöhrl; Heimo Breiteneder Journal: Allergy Date: 2021-05-02 Impact factor: 14.710
Authors: Giovanni Birrueta; April Frazier; Anna Pomés; Jill Glesner; Stephanie Filep; Coby Schal; Kyoung Yong Jeong; Curtis McMurtrey; Thomas Vander Schans; William H Hildebrand; Paula Busse; Avraham Beigelman; Leonard B Bacharier; Bjoern Peters; Alessandro Sette; Véronique Schulten Journal: Front Immunol Date: 2019-02-27 Impact factor: 7.561
Authors: Anna Pomés; Véronique Schulten; Jill Glesner; Ricardo da Silva Antunes; Aaron Sutherland; Leonard B Bacharier; Avraham Beigelman; Paula Busse; April Frazier; Alessandro Sette Journal: Front Immunol Date: 2021-02-10 Impact factor: 7.561
Authors: Celia López-Sanz; Rodrigo Jiménez-Saiz; Vanesa Esteban; María Isabel Delgado-Dolset; Carolina Perales-Chorda; Alma Villaseñor; Domingo Barber; María M Escribese Journal: Front Allergy Date: 2022-06-16
Authors: Luis Caraballo; Rudolf Valenta; Leonardo Puerta; Anna Pomés; Josefina Zakzuk; Enrique Fernandez-Caldas; Nathalie Acevedo; Mario Sanchez-Borges; Ignacio Ansotegui; Luo Zhang; Marianne van Hage; Eva Fernández; Luisa Arruda; Susanne Vrtala; Mirela Curin; Hans Gronlund; Antonina Karsonova; Jonathan Kilimajer; Ksenja Riabova; Daria Trifonova; Alexander Karaulov Journal: World Allergy Organ J Date: 2020-04-29 Impact factor: 4.084
Authors: Ricardo da Silva Antunes; Aaron Sutherland; April Frazier; Veronique Schulten; Anna Pomés; Jill Glesner; Agustin Calatroni; Matthew C Altman; Robert A Wood; George T O'Connor; Jacqueline A Pongracic; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Michelle Gill; Andrew H Liu; Edward Zoratti; Meyer Kattan; Paula J Busse; Leonard B Bacharier; Stephen J Teach; Lisa M Wheatley; Alkis Togias; William W Busse; Daniel J Jackson; Alessandro Sette Journal: Clin Transl Allergy Date: 2021-10-13 Impact factor: 5.871